港股IPO爆发，10家A股千亿巨头涌入

Core Insights - The Hong Kong IPO market is experiencing significant growth, with 15 new listings in 2026, a 87.50% increase year-on-year, and total fundraising amounting to 51.307 billion HKD, a 757.71% increase [1] - The market is expected to maintain high levels of IPO activity in 2026, with a consensus among industry experts [1][6] - A substantial number of companies are in the pipeline for IPOs, with over 270 applications, including 93 A+H companies [4][9] Group 1: IPO Market Overview - The Hong Kong IPO market has seen a remarkable increase in new listings and fundraising, with Eastroc Beverage's IPO being the first to exceed 10 billion HKD in 2026 [1] - The total IPO expenses for 114 companies in 2025 amounted to approximately 12.116 billion HKD, reflecting a significant increase from the previous year [4] - The market is characterized by a diverse range of industries, with software services, healthcare, and industrial manufacturing being the most represented sectors [4] Group 2: Future Projections - Deloitte predicts around 160 new IPOs in 2026, raising at least 300 billion HKD, while PwC estimates between 150 to 175 IPOs with total fundraising between 320 billion to 350 billion HKD [6] - The trend of A+H companies going public is expected to continue, driven by the need for international financing channels [9] - The 18A and 18C listing rules have significantly enhanced the attractiveness of the Hong Kong market for biotech and tech companies, with a notable increase in applications under these categories [11][13] Group 3: A+H Companies and Market Dynamics - In 2025, A-share companies contributed significantly to the Hong Kong IPO market, with 19 new A+H listings raising a total of 126.946 billion HKD [8] - There are currently 9 A-share companies with a market capitalization exceeding 100 billion HKD waiting to list in Hong Kong [8] - The influx of A+H companies is expected to bring high-quality assets to the market, enhancing overall market quality and international appeal [9] Group 4: Biotech and Tech Sector Developments - The 18A listing rule has positioned Hong Kong as a key international financing hub for biotech, with 16 companies listed in 2025 [11] - The 18C rule has attracted numerous tech companies, with a significant increase in fundraising from these firms in 2025 [13] - The diversity of sectors represented in the IPO pipeline indicates a growing trend towards high-end manufacturing and technological innovation [14]